Published Date：Mar.2021
Industry：Chemical & Material
Pages：127 Table Number：144
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Neutropenia Biologic Drug Treatment market in this environment. In terms of revenue, this research report indicated that the global Neutropenia Biologic Drug Treatment market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Neutropenia Biologic Drug Treatment industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Teva Pharmaceutical aims at producing XX Neutropenia Biologic Drug Treatment in 2020, with XX % production to take place in global market, Amgen accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Neutropenia Biologic Drug Treatment Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Neutropenia Biologic Drug Treatment Market? Teva Pharmaceutical Amgen Sanofi Mylan Kyowa Kirin Baxter International CVS Health Corp Novartis Spectrum Pharmaceuticals Partner Therapeutics Pfizer Myelo Therapeutics Cellerant Therapeutics Sandoz (Subsidary of Novartis AG) BeyondSpring Pharmaceuticals Enzychem Lifesciences Corporation Tianjin SinoBiotech S&D Pharma SK s.r.o. Generon (Shanghai) Corporation Ltd. PhytoHealth Corporation Dong-A ST Co. ... Major Type of Neutropenia Biologic Drug Treatment Covered in XYZResearch report: Filgrastim Pegfilgrastim Lenograstim Lipegfilgrastim Sargramostim Application Segments Covered in XYZResearch Market Retail Pharmacies Hospital Pharmacies Online Pharmacies For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Neutropenia Biologic Drug Treatment Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Filgrastim -Product Introduction and Major Manufacturers 1.1.2 Pegfilgrastim -Product Introduction and Major Manufacturers 1.1.3 Lenograstim -Product Introduction and Major Manufacturers 1.1.4 Lipegfilgrastim -Product Introduction and Major Manufacturers 1.1.5 Sargramostim -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Neutropenia Biologic Drug Treatment Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Neutropenia Biologic Drug Treatment Market 3.1.1 Top Companies leading Neutropenia Biologic Drug Treatment Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Neutropenia Biologic Drug Treatment Market 3.2.1 Top Companies leading Neutropenia Biologic Drug Treatment Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Neutropenia Biologic Drug Treatment Market 3.3.1 Top Companies leading Neutropenia Biologic Drug Treatment Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Neutropenia Biologic Drug Treatment Market 3.4.1 Top Companies leading Neutropenia Biologic Drug Treatment Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Neutropenia Biologic Drug Treatment Market 3.5.1 Top Companies leading Neutropenia Biologic Drug Treatment Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Neutropenia Biologic Drug Treatment Market 3.6.1 Top Companies leading Neutropenia Biologic Drug Treatment Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Neutropenia Biologic Drug Treatment Market 3.7.1 Top Companies leading Neutropenia Biologic Drug Treatment Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Neutropenia Biologic Drug Treatment Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Neutropenia Biologic Drug Treatment Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Neutropenia Biologic Drug Treatment Sales and Growth Rate (2021-2026) 5.2 Global Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2021-2026) 6 Neutropenia Biologic Drug Treatment Competitive Analysis 6.1 Teva Pharmaceutical 6.1.1 Teva Pharmaceutical Company Profiles 6.1.2 Teva Pharmaceutical Product Introduction 6.1.3 Teva Pharmaceutical Neutropenia Biologic Drug Treatment Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Amgen 6.2.1 Amgen Company Profiles 6.2.2 Amgen Product Introduction 6.2.3 Amgen Neutropenia Biologic Drug Treatment Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Sanofi 6.3.1 Sanofi Company Profiles 6.3.2 Sanofi Product Introduction 6.3.3 Sanofi Neutropenia Biologic Drug Treatment Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Mylan 6.4.1 Mylan Company Profiles 6.4.2 Mylan Product Introduction 6.4.3 Mylan Neutropenia Biologic Drug Treatment Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Kyowa Kirin 6.5.1 Kyowa Kirin Company Profiles 6.5.2 Kyowa Kirin Product Introduction 6.5.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Baxter International 6.6.1 Baxter International Company Profiles 6.6.2 Baxter International Product Introduction 6.6.3 Baxter International Neutropenia Biologic Drug Treatment Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 CVS Health Corp 6.7.1 CVS Health Corp Company Profiles 6.7.2 CVS Health Corp Product Introduction 6.7.3 CVS Health Corp Neutropenia Biologic Drug Treatment Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 Novartis 6.8.1 Novartis Company Profiles 6.8.2 Novartis Product Introduction 6.8.3 Novartis Neutropenia Biologic Drug Treatment Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Spectrum Pharmaceuticals 6.9.1 Spectrum Pharmaceuticals Company Profiles 6.9.2 Spectrum Pharmaceuticals Product Introduction 6.9.3 Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 6.10 Partner Therapeutics 6.10.1 Partner Therapeutics Company Profiles 6.10.2 Partner Therapeutics Product Introduction 6.10.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Production, Revenue (2015-2020) 6.10.4 SWOT Analysis 6.11 Pfizer 6.12 Myelo Therapeutics 6.13 Cellerant Therapeutics 6.14 Sandoz (Subsidary of Novartis AG) 6.15 BeyondSpring Pharmaceuticals 6.16 Enzychem Lifesciences Corporation 6.17 Tianjin SinoBiotech 6.18 S&D Pharma SK s.r.o. 6.19 Generon (Shanghai) Corporation Ltd. 6.20 PhytoHealth Corporation 6.21 Dong-A ST Co. 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Neutropenia Biologic Drug Treatment Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Neutropenia Biologic Drug Treatment Sales (K Unit) by Type (2015-2026) Figure Global Neutropenia Biologic Drug Treatment Sales (K Unit) and Growth Rate (2015-2026) Figure Global Neutropenia Biologic Drug Treatment Sales Market Share (%) by Type (2019 -2020) Table Global Neutropenia Biologic Drug Treatment Sales Value (Million USD) by Type (2015-2026) Figure Global Neutropenia Biologic Drug Treatment Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Neutropenia Biologic Drug Treatment Sales Value Market Share (%) by Type (2019-2020) Table Global Neutropenia Biologic Drug Treatment Sales (K Unit) by Application (2015-2026) Table China Neutropenia Biologic Drug Treatment Sales (K Unit) of Major Company (2015-2020) Table China Neutropenia Biologic Drug Treatment Sales Market Share of Major Company (2015-2020) Table China Neutropenia Biologic Drug Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure China Neutropenia Biologic Drug Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table China Neutropenia Biologic Drug Treatment Sales Value Share of Major Company (2015-2020) Table China Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) Table China Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Figure China Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Table EU Neutropenia Biologic Drug Treatment Sales (K Unit) of Major Company (2015-2020) Table EU Neutropenia Biologic Drug Treatment Sales Market Share of Major Company (2015-2020) Table EU Neutropenia Biologic Drug Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure EU Neutropenia Biologic Drug Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Neutropenia Biologic Drug Treatment Sales Value Share of Major Company (2015-2020) Table EU Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) Table EU Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Figure EU Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Table USA Neutropenia Biologic Drug Treatment Sales (K Unit) of Major Company (2015-2020) Table USA Neutropenia Biologic Drug Treatment Sales Market Share of Major Company (2015-2020) Table USA Neutropenia Biologic Drug Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure USA Neutropenia Biologic Drug Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Neutropenia Biologic Drug Treatment Sales Value Share of Major Company (2015-2020) Table USA Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) Table USA Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Figure USA Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Table Japan Neutropenia Biologic Drug Treatment Sales (K Unit) of Major Company (2015-2020) Table Japan Neutropenia Biologic Drug Treatment Sales Market Share of Major Company (2015-2020) Table Japan Neutropenia Biologic Drug Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Neutropenia Biologic Drug Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Neutropenia Biologic Drug Treatment Sales Value Share of Major Company (2015-2020) Table Japan Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) Table Japan Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Figure Japan Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Table India Neutropenia Biologic Drug Treatment Sales (K Unit) of Major Company (2015-2020) Table India Neutropenia Biologic Drug Treatment Sales Market Share of Major Company (2015-2020) Table India Neutropenia Biologic Drug Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure India Neutropenia Biologic Drug Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table India Neutropenia Biologic Drug Treatment Sales Value Share of Major Company (2015-2020) Table India Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) Table India Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Figure India Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Table Southeast Asia Neutropenia Biologic Drug Treatment Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Neutropenia Biologic Drug Treatment Sales Market Share of Major Company (2015-2020) Table Southeast Asia Neutropenia Biologic Drug Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Neutropenia Biologic Drug Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Neutropenia Biologic Drug Treatment Sales Value Share of Major Company (2015-2020) Table Southeast Asia Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Figure Southeast Asia Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Table South America Neutropenia Biologic Drug Treatment Sales (K Unit) of Major Company (2015-2020) Table South America Neutropenia Biologic Drug Treatment Sales Market Share of Major Company (2015-2020) Table South America Neutropenia Biologic Drug Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure South America Neutropenia Biologic Drug Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Neutropenia Biologic Drug Treatment Sales Value Share of Major Company (2015-2020) Table South America Neutropenia Biologic Drug Treatment Price (USD/Unit), by Type (2019-2020) Table South America Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Figure South America Neutropenia Biologic Drug Treatment Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Neutropenia Biologic Drug Treatment Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Neutropenia Biologic Drug Treatment Figure Cost Structure of Neutropenia Biologic Drug Treatment in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Neutropenia Biologic Drug Treatment Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Neutropenia Biologic Drug Treatment Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table Teva Pharmaceutical Profiles Table Teva Pharmaceutical Neutropenia Biologic Drug Treatment Product Introduction Table Teva Pharmaceutical Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Teva Pharmaceutical SWOT Analysis Table Amgen Profiles Table Amgen Neutropenia Biologic Drug Treatment Product Introduction Table Amgen Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Amgen SWOT Analysis Table Sanofi Profiles Table Sanofi Neutropenia Biologic Drug Treatment Product Introduction Table Sanofi Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Sanofi SWOT Analysis Table Mylan Profiles Table Mylan Neutropenia Biologic Drug Treatment Product Introduction Table Mylan Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Mylan SWOT Analysis Table Kyowa Kirin Profiles Table Kyowa Kirin Neutropenia Biologic Drug Treatment Product Introduction Table Kyowa Kirin Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Kyowa Kirin SWOT Analysis Table Baxter International Profiles Table Baxter International Neutropenia Biologic Drug Treatment Product Introduction Table Baxter International Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Baxter International SWOT Analysis Table CVS Health Corp Profiles Table CVS Health Corp Neutropenia Biologic Drug Treatment Product Introduction Table CVS Health Corp Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure CVS Health Corp SWOT Analysis Table Novartis Profiles Table Novartis Neutropenia Biologic Drug Treatment Product Introduction Table Novartis Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Novartis SWOT Analysis Table Spectrum Pharmaceuticals Profiles Table Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Product Introduction Table Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Spectrum Pharmaceuticals SWOT Analysis Table Partner Therapeutics Profiles Table Partner Therapeutics Neutropenia Biologic Drug Treatment Product Introduction Table Partner Therapeutics Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Partner Therapeutics SWOT Analysis Table Pfizer Profiles Table Pfizer Neutropenia Biologic Drug Treatment Product Introduction Table Pfizer Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Pfizer SWOT Analysis Table Myelo Therapeutics Profiles Table Myelo Therapeutics Neutropenia Biologic Drug Treatment Product Introduction Table Myelo Therapeutics Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Myelo Therapeutics SWOT Analysis Table Cellerant Therapeutics Profiles Table Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Introduction Table Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Cellerant Therapeutics SWOT Analysis Table Sandoz (Subsidary of Novartis AG) Profiles Table Sandoz (Subsidary of Novartis AG) Neutropenia Biologic Drug Treatment Product Introduction Table Sandoz (Subsidary of Novartis AG) Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Sandoz (Subsidary of Novartis AG) SWOT Analysis Table BeyondSpring Pharmaceuticals Profiles Table BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Product Introduction Table BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure BeyondSpring Pharmaceuticals SWOT Analysis Table Enzychem Lifesciences Corporation Profiles Table Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Introduction Table Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Enzychem Lifesciences Corporation SWOT Analysis Table Tianjin SinoBiotech Profiles Table Tianjin SinoBiotech Neutropenia Biologic Drug Treatment Product Introduction Table Tianjin SinoBiotech Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Tianjin SinoBiotech SWOT Analysis Table S&D Pharma SK s.r.o. Profiles Table S&D Pharma SK s.r.o. Neutropenia Biologic Drug Treatment Product Introduction Table S&D Pharma SK s.r.o. Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure S&D Pharma SK s.r.o. SWOT Analysis Table Generon (Shanghai) Corporation Ltd. Profiles Table Generon (Shanghai) Corporation Ltd. Neutropenia Biologic Drug Treatment Product Introduction Table Generon (Shanghai) Corporation Ltd. Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Generon (Shanghai) Corporation Ltd. SWOT Analysis Table PhytoHealth Corporation Profiles Table PhytoHealth Corporation Neutropenia Biologic Drug Treatment Product Introduction Table PhytoHealth Corporation Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure PhytoHealth Corporation SWOT Analysis Table Dong-A ST Co. Profiles Table Dong-A ST Co. Neutropenia Biologic Drug Treatment Product Introduction Table Dong-A ST Co. Neutropenia Biologic Drug Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
